Literature DB >> 11014973

Antiphospholipid syndrome.

E Gromnica-Ihle1, W Schössler.   

Abstract

Antiphospholipid syndrome (APS) is a disease characterized by venous and arterial thromboses or spontaneous abortions and the repeated detection of antiphospholipid antibodies (aPL). APS may be associated with another autoimmune disease (secondary APS), particularly systemic lupus erythematosus (SLE), or unrelated to an underlying disease (primary APS). APS affects almost all organs. In addition to the clinical criteria, lupus anticoagulant testing and immunological aPL determinations are required to establish the diagnosis of APS. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 11014973     DOI: 10.1159/000024425

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

Review 1.  [Diagnosis of the antiphospholipid syndrome in anticoagulated patients].

Authors:  M Mohren; T Daikeler; A Engel; I Guenaydin; I Koetter
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

2.  Cerebral embolism from Libman-Sacks endocarditis.

Authors:  Beatriz Malvar; Filipa Mendonça Almeida; Luisa Rebocho; Jose Carlos Moniz; Francisco Azevedo
Journal:  BMJ Case Rep       Date:  2011-06-30

3.  Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome.

Authors:  Yasutaka Tanaka; Yuji Ueno; Nobukazu Miyamoto; Yoshiaki Shimada; Ryota Tanaka; Nobutaka Hattori; Takao Urabe
Journal:  J Neurol       Date:  2012-07-27       Impact factor: 4.849

4.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31

5.  Thrombolytic therapy for cerebral vein thrombosis in antiphospholipid syndrome secondary to systemic lupus erythematosus.

Authors:  Mehrzad Hajialilo; Hamid Noshad; Reza Mohammadian; Ali Reza Khabbazi; Mohammad Hossein Daghighi; Parviz Saleh
Journal:  Iran J Med Sci       Date:  2012-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.